Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026)

Becton Dickinson's (BDX) quarterly Total Non-Current Liabilities came in at $48.4 billion in Q1 2026, down 6.02% year-on-year from $51.5 billion in Q1 2025, and down 7.02% on a QoQ basis from $52.0 billion in Q4 2025.

Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Total Non-Current Liabilities data on file, last reported at $48.4 billion in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 6.02% year-over-year to $48.4 billion in Q1 2026; TTM through Mar 2026 was $48.4 billion, a 6.02% decrease from a year earlier, with the FY2025 full-year figure at $52.7 billion, down 1.93% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $48.4 billion, down from $52.0 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for BDX reached as high as $53.7 billion in Q3 2024 and fell as low as $47.9 billion in Q4 2023.
  • Historically, Total Non-Current Liabilities has averaged $50.1 billion across 5 years, with a median of $49.9 billion in 2024.
  • Across the five-year window, Total Non-Current Liabilities rose 11.47% in 2024 and dropped 6.02% in 2026, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $48.3 billion in 2022, then retreated by 0.84% to $47.9 billion in 2023, then increased by 7.08% to $51.2 billion in 2024, then advanced by 1.52% to $52.0 billion in 2025, then retreated by 7.02% to $48.4 billion in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $48.4 billion in Q1 2026, $52.0 billion in Q4 2025, and $52.7 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 6.48 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 1.92 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 48.37 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 17.13 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 941.16 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 996.30 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.24 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 8.65 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.06 Bn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn 12.54 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 48.37 Bn
Dec 31, 2025 52.03 Bn
Sep 30, 2025 52.69 Bn
Jun 30, 2025 52.07 Bn
Mar 31, 2025 51.47 Bn
Dec 31, 2024 51.25 Bn
Sep 30, 2024 53.73 Bn
Jun 30, 2024 51.51 Bn
Mar 31, 2024 49.86 Bn
Dec 31, 2023 47.86 Bn
Sep 30, 2023 48.20 Bn
Jun 30, 2023 48.64 Bn
Mar 31, 2023 49.92 Bn
Dec 31, 2022 48.27 Bn
Sep 30, 2022 47.88 Bn
Jun 30, 2022 48.27 Bn
Mar 31, 2022 49.81 Bn
Dec 31, 2021 48.33 Bn
Sep 30, 2021 48.66 Bn
Jun 30, 2021 49.00 Bn